Basant Atef Ahmed

Dr. Basant Atef Ahmed

Tanta University Faculty of Medicine, Ţanţā, Al Gharbīyah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Current Treatment Options in Pediatrics
Verified
Journal Article
Open access
PDF file
WSWafaa Shehada
Wafaa Shehada
COChibuike Daniel Onyejesi
Chibuike Daniel Onyejesi
MRMuskaan Doulat Ram
Muskaan Doulat Ram
SCShamikha Cheema
Shamikha Cheema
KFKarim Fahmy
Karim Fahmy
MAMohammed Alsabri
Mohammed Alsabri
Purpose of review: This review aims to provide a comprehensive overview of the epidemiology, risk factors, diagnostic strategies, and management of periorbital and orbital cellulitis in children. By synthesizing current evidence, we aim to support the development of an evidence-based clinical guidance to aid in the accurate differentiation and effective treatment of these conditions, reducing complications. Recent findings: Recent literature emphasizes the clinical challenge in distinguishing between periorbital and orbital cellulitis due to overlapping symptoms. Imaging modalities such as CT and MRI, alongside targeted laboratory testing and careful clinical evaluation, are critical for accurate diagnosis. Studies also highlight the importance of prompt and appropriate antibiotic therapy tailored to pediatric populations to prevent progression and complications. Summary: This review offers pediatric emergency medicine clinicians a practical framework for early and accurate diagnosis of periorbital and orbital cellulitis. We emphasize the importance of timely intervention and appropriate diagnostic tools to improve outcomes. Further research should aim to refine diagnostic criteria and develop personalized treatment strategies for pediatric patients.

10 March 2026 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
ABAhmed Reda Bahr
Ahmed Reda Bahr
IAIbrahim Saleh Alawadi
Ibrahim Saleh Alawadi
LALaila Mohamed Akr
Laila Mohamed Akr
Basant Atef AhmedBasant Atef Ahmed
Basant Atef Ahmed
Jaber H. JaradatJaber H. Jaradat
Jaber H. Jaradat
OHOmar Hamdy
Omar Hamdy

4 August 2025 in Current Emergency and Hospital Medicine Reports
Verified
Journal Article
Closed access
PDF file
DADina Essam Abo-Elnour
Dina Essam Abo-Elnour
Basant Atef AhmedBasant Atef Ahmed
Basant Atef Ahmed
MGMohamed Mabrouk Ghonaim
Mohamed Mabrouk Ghonaim
AIArham Iqbal
Arham Iqbal
Okesanya John OlalekanOkesanya John Olalekan
Okesanya John Olalekan
MAMohammed Alsabri
Mohammed Alsabri

30 August 2026 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
RIRowan A. E. Ibrahim
Rowan A. E. Ibrahim
Basant Atef AhmedBasant Atef Ahmed
Basant Atef Ahmed
ABAhmed Reda Bahr
Ahmed Reda Bahr
MEMohammed ElShazly
Mohammed ElShazly
1. Hodgkin Lymphoma is a rare type of lymphoma with unique pathobiology and immunophenotypic characteristics. According to GLOBOCAN projections, the global incidence of new cases is expected to ris...

20 July 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAhmed Reda Bahr
Ahmed Reda Bahr
Basant Atef AhmedBasant Atef Ahmed
Basant Atef Ahmed
HAHebatalla Abdelmaksoud Abdelmonsef Ahmed
Hebatalla Abdelmaksoud Abdelmonsef Ahmed
IYIbrahim A. Yakout
Ibrahim A. Yakout
MAMohamed K. Abdelhamid
Mohamed K. Abdelhamid
OHOmar Hamdy
Omar Hamdy
Chemotherapeutic agents serve as a fundamental treatment approach for numerous cancer types. Providing patients with comprehensive information about chemotherapy’s purposes, advantages, disadvantages, and management strategies is crucial for decreasing anxiety, boosting treatment compliance, and improving general well-being. This study aims to measure the knowledge, attitude, and response ( KAR) scores among cancer patients, in addition to identifying the potential associated factors for high scores. This observational cross-sectional study was conducted at the Oncology Center, Mansoura University, a tertiary care center, between September 2025 and October 2025. The study enrolled 669 cancer patients aged 18 years and above. Data were collected via a structured, Arabic-translated questionnaire developed from previous literature to assess KAR toward chemotherapy. Content validity was confirmed by three oncologists. Reliability and construct validity were evaluated using Cronbach’s alpha and exploratory factor analysis. Associated factors of total A-KAR scores were identified using univariate and multiple linear regression. A total of 669 patients participated with a mean age of 51.5 ± 13.2 years, predominantly female (68.2%). The mean knowledge score was 5.4 ± 2.3 out of 10, the mean attitude score was 10.8 ± 2.1 out of 15, and the mean response score was 2.7 ± 0.6 out of 3, with an overall total A-KAR score of 18.9 ± 3.9 (range: 5–28). Females exhibited significantly higher knowledge, attitude, and total A-KAR scores than males ( p < 0.001). In the multiple regression model, higher A-KAR scores were independently predicted by female gender (β = − 0.329, p < 0.001), urban residency (β = 0.175, p = 0.037), absence of a family history of malignancy (β = − 0.164, p = 0.027), and receiving chemotherapy (β = − 0.478, p = 0.012). Duration since chemotherapy initiation was a strong independent associated factor, with significantly lower scores among those treated for less than one year compared with those treated for one to three years (all p < 0.001). Cancer patients demonstrated moderate overall knowledge and attitudes toward chemotherapy, with generally positive response behaviors. Several sociodemographic and clinical factors were significant independent associated factors of A-KAR scores. These findings highlight the need for targeted educational interventions that address knowledge gaps and support patients throughout their treatment journey.

5 November 2026 in Cancers
Verified
Journal Article
Open access
PDF file
OHOmar Hamdy
Omar Hamdy
EEEman Eid
Eman Eid
RRRana Reda
Rana Reda
AEAhmad E. Eladl
Ahmad E. Eladl
MHMariam Harby
Mariam Harby
MEMohamed mohamed Elbadrawy
Mohamed mohamed Elbadrawy
Background: Kaposi sarcoma (KS) is an unusual disease that presents in various clinical forms, leading to variable treatment plans. In this study, we present our center’s experience with the diagnosis and management of KS in a non-endemic area, aiming to highlight the distinctive characteristics of this disease in our locality. Methods: This is a retrospective study that included all patients with KS who presented to our center between January 2008 and December 2025. The epidemiological, clinical, therapeutic, and prognostic data were analyzed. Given the limited number of events, all survival and regression analyses were exploratory and hypothesis-generating. Results: A total of 56 patients with KS (predominantly male: 46/56, 82.1%) were included in the study. The median age at diagnosis was 61 years. HIV seropositivity was documented in 13 patients (23.6%), HCV in 11 (21.2%), and HBV in one patient (1.9%). Nodular morphology was the most common presentation, followed by plaque-type and patch-stage. More than 50 lesions were observed at presentation in 25 patients. The median largest tumor diameter was 2.0 cm (range: 0.5–30.0 cm). Systemic chemotherapy was administered to 29 patients (51.8%), representing the most common initial approach. Surgical excision alone was performed in 13 patients (23.2%), radiotherapy alone in 3 (5.4%), cryotherapy alone in 2 (3.6%), and intralesional chemotherapy in 2 (3.6%). Local recurrence occurred in 12.5% of patients, with the median time to recurrence of 17 months, and positive lymph node status at diagnosis was the only variable associated with local recurrence in exploratory univariate analysis. Metastatic disease developed in 16.1% of patients, with a median time to metastasis of 10 months, and nodular lesion morphology and Ki-67 proliferation index were associated with metastasis in exploratory multivariate analysis. At a median follow-up of 40 months, 9 deaths (16.1%) were recorded. HIV-positive status was associated with worse overall survival (OS). These findings require validation in larger, adequately powered cohorts. Conclusions: While KS generally shows an indolent behavior, exploratory analysis suggests that nodular morphology, high Ki-67, lymph node involvement, and HIV seropositivity may be associated with worse outcomes. Systemic therapy remains the most frequently used treatment for advanced disease, while surgery and radiotherapy are appropriate options for selected localized lesions. These findings should be considered hypothesis-generating and require confirmation in larger, prospective, multicenter studies.